Add listing
    0
    Add listing
    Listing cover image

    ArtBio GmbH Verified listing

    • Swiss Biotech Association
      Member

    ARTBIO is a clinical-stage radiopharmaceutical company focused on developing a new class of alpha radioligand therapies (ARTs) to transform cancer treatment. ARTBIO's approach centers on utilizing the alpha-emitting isotope Pb212 to target cancer cells while minimizing damage to healthy tissues.

    Location
    Canton
    Facts & figures
    • Type of organization
      Private company
    • Number of employees in Switzerland
      10-19
    Key business

    You may also be interested in